Search

Your search keyword '"Rilpivirine -- Product development -- Research"' showing total 2 results
Start Over Descriptor "Rilpivirine -- Product development -- Research" Publisher right vision media
2 results on '"Rilpivirine -- Product development -- Research"'

1. ViiV Healthcare Presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation

Subjects
Medical research, Medicine, Experimental, Rilpivirine -- Product development -- Research, Sexually transmitted diseases -- Prevention, Clinical trials -- Research, General interest, News, opinion and commentary
Abstract

LONDON: ViiV Healthcare announces positive findings from its phase I study showing that an investigational formulation of cabotegravir, known as cabotegravir ultra long-acting (CAB-ULA), can be dosed at intervals of [...]

Published
2024

2. ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses

Subjects
Pfizer Inc. -- Product development, Medical research, Medicine, Experimental, Rilpivirine -- Product development -- Research, Clinical trials -- Research, Pharmaceutical industry -- Product development, Business, international
Abstract

Brentford, London, United: GlaxoSmithKline has issued the following press release: Data show for the first time a new ultra long-acting cabotegravir formulation (CAB-ULA) that doubles the current dosing interval Pharmacokinetic, [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results